Nicholas Piramal Q2 net up 86%

By SiliconIndia   |   Thursday, 24 October 2002, 07:00 Hrs
Printer Print Email Email
Nicholas Piramal, one of India's largest pharmaceutical companies has posted a net profit of Rs 261.50 million for the quarter ended September 30, 2002.


BANGALORE: The company had posted a net profit of Rs 140.80 million in the quarter ended September 30, 2001. Total Income has increased from Rs 2522.40 million in the quarter ended September 30, 2001 to Rs 2697.70 million in the quarter ended September 30, 2002.

The company also announced a change in the management structure with S Ramadorai coming on board as a director.

The company also announced that Dr Swati A Piramal has been re-appointed as Director in Wholetime employment of the company (designated as Director Alliances & Communications) for a period of five years with effect from November 19, 2002 subject to approval of the shareholders, which would be obtained at the next AGM of the company.


SPOTLIGHT
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..